Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer

Hidetaka A. Ono, Julia G. Davydova, Yasuo Adachi, Koichi Takayama, Shannon D. Barker, Paul N. Reynolds, Victor N. Krasnykh, Chikara Kunisaki, Hiroshi Shimada, David T. Curiel, Masato Yamamoto

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

Background: Gastric cancer is the fourth most common malignancy worldwide. Adenoviral vectors (Ads) have been applied for gene therapy of various cancers because of their high transduction efficiency. However, the infectivity of gastrointestinal cancer cells is poor due to the limited expression of the Coxsackie-adenovirus receptor (CAR). In addition, few tumor-specific promoters (TSPs) have been characterized for this type of cancer. To overcome these problems, we proposed TSP-driven conditionally replicating adenoviruses (CRAds) with fiber modification for virotherapy of gastric cancer. Methods: We assessed the expression profile of eight TSPs in gastric cancer cell lines and evaluated promising candidates in the context of CRAd cytocidal effect. Next, infectivity enhancement by fiber modifications was analyzed in the gastric cancer cell lines. Finally, we combined the TSP-driven CRAds of choice with the fiber modifications to augment the killing effect. Results: Out of the eight TSPs, the midkine (MK) and cyclooxygenase-2 (Cox-2M and Cox-2L) promoters showed high transcriptional activity in gastric cancer cells. When these promoters were used in a CRAd context, Cox-2 CRAds elicited the strongest cytocidal effect. The greatest infectivity enhancement was observed with adenoviral vectors displaying 5/3 chimeric fibers. Likewise, Cox-2 CRAds with 5/3 chimeric fibers showed the strongest cytocidal effect in gastric cancer cell lines. Therefore, Cox-2 CRAds with 5/3 chimeric fiber modification showed good selectivity and infectivity in gastric cancer cells to yield enhanced oncolysis. Conclusions: Cox-2 CRAds with 5/3 chimeric fiber modification are promising for virotherapy of gastric cancer.

Original languageEnglish
Pages (from-to)31-42
Number of pages12
JournalJournal of Gastroenterology
Volume40
Issue number1
DOIs
StatePublished - Jan 2005

Keywords

  • Conditionally replicative adenoviral vectors
  • Cytocidal effect
  • Fiber modification
  • Gastric cancer
  • Tumor-specific promoter

Fingerprint

Dive into the research topics of 'Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer'. Together they form a unique fingerprint.

Cite this